NCT04145128View on ClinicalTrials.gov

A Study to Evaluate AG-881 in Healthy Japanese and Non-Asian Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

December 11, 2019

Study Completion Date

December 18, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

AG881

AG-881 tablets.

Trial Locations (1)

90630

WCCT GLobal, Cypress

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY